The global immunoassay market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–7% over the ...
TETRAPHARM, a Copenhagen-based biopharmaceutical company focused on neuroscience, psychiatry, and metabolic disorders, today announced promising preclinical data for TPC-026, a novel investigational ...
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only continuing operations and period-to-period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results